Herbalife (HLF) Competitors

Herbalife (NYSE:HLF) and Prestige Consumer Healthcare (NYSE:PBH) are both personal products companies, but which is the superior investment? We will compare the two businesses based on the strength of their valuation, analyst recommendations, media sentiment, profitability, institutional ownership, risk, dividends and earnings.

Do analysts prefer HLF or PBH?

Herbalife currently has a consensus target price of $11.50, suggesting a potential upside of 24.06%. Prestige Consumer Healthcare has a consensus target price of $93.33, suggesting a potential upside of 23.29%. Given Herbalife's stronger consensus rating and higher probable upside, research analysts clearly believe Herbalife is more favorable than Prestige Consumer Healthcare.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Herbalife	0 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.75
Prestige Consumer Healthcare	0 Sell rating(s)	3 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.50

Does the media prefer HLF or PBH?

In the previous week, Prestige Consumer Healthcare had 7 more articles in the media than Herbalife. MarketBeat recorded 11 mentions for Prestige Consumer Healthcare and 4 mentions for Herbalife. Prestige Consumer Healthcare's average media sentiment score of 1.15 beat Herbalife's score of 0.78 indicating that Prestige Consumer Healthcare is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Herbalife	2 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive
Prestige Consumer Healthcare	6 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Which has more risk and volatility, HLF or PBH?

Herbalife has a beta of 0.89, indicating that its stock price is 11% less volatile than the S&P 500. Comparatively, Prestige Consumer Healthcare has a beta of 0.43, indicating that its stock price is 57% less volatile than the S&P 500.

Do insiders and institutionals hold more shares of HLF or PBH?

99.9% of Prestige Consumer Healthcare shares are owned by institutional investors. 1.7% of Herbalife shares are owned by company insiders. Comparatively, 1.4% of Prestige Consumer Healthcare shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Is HLF or PBH more profitable?

Prestige Consumer Healthcare has a net margin of 18.86% compared to Herbalife's net margin of 5.66%. Prestige Consumer Healthcare's return on equity of 12.87% beat Herbalife's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Herbalife	5.66%	-23.75%	7.86%
Prestige Consumer Healthcare	18.86%	12.87%	6.78%

Which has stronger earnings and valuation, HLF or PBH?

Herbalife has higher revenue and earnings than Prestige Consumer Healthcare. Herbalife is trading at a lower price-to-earnings ratio than Prestige Consumer Healthcare, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Herbalife	$4.99B	0.19	$254.30M	$2.74	3.38
Prestige Consumer Healthcare	$1.14B	3.29	$214.60M	$4.29	17.65

Summary

Prestige Consumer Healthcare beats Herbalife on 8 of the 15 factors compared between the two stocks.